Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country symbols : BDX save search
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: 0.61%
H: 0.0%
C: 0.0%
ANGO | $6.22 1.63% 250K
|
Health Technology
|
| O: 1.43%
H: 12.5%
C: 0.0%
year financial
BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems
Published: 2023-12-04 (Crawled : 00:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -0.39%
H: 0.52%
C: 0.11%
BD Advances "One-Stick Hospital Stay" Vision with Launch of Next-Generation Needle-Free Blood Draw Technology
Published: 2023-11-02 (Crawled : 11:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: 0.0%
H: 1.45%
C: 0.84%
hospital blood technology
BD, Casella Complete Industry-First Pilot Recycling 40,000 Pounds of Used Medical Devices
Published: 2023-10-16 (Crawled : 12:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: 0.46%
H: 0.64%
C: -0.05%
CWST | $92.875 0.55% 68K
|
Industrial Services
|
| O: 0.21%
H: 2.0%
C: 1.58%
medical pilot
BD Launches World's First Spectral Cell Sorter with High-Speed Cell Imaging
Published: 2023-05-18 (Crawled : 12:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -0.16%
H: 0.47%
C: 0.28%
cell imaging
BD Reports Second Quarter Fiscal 2023 Financial Results
Published: 2023-05-04 (Crawled : 11:00) - biospace.com/
EMBC | $10.59 2.32% 130K
|
n/a
|
| O: -0.45%
H: 0.0%
C: -1.38%
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -2.9%
financial results
BD Introduces Advanced Ultrasound Technology to Help Drive First-Stick Success for IV Insertions
Published: 2023-04-11 (Crawled : 12:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: 0.2%
H: 0.59%
C: -0.41%
success technology
BD Receives FDA Emergency Use Authorization for COVID-19, Influenza A/B, RSV Combination Test
Published: 2023-02-08 (Crawled : 15:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -0.32%
H: 0.29%
C: -0.85%
covid-19 fda test rsv authorization influenza
BD Publishes 2022 Cybersecurity Annual Report
Published: 2023-01-25 (Crawled : 14:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -0.52%
H: 0.95%
C: 0.95%
report cybersecurity
BD to Present at Evercore ISI 5th Annual HealthCONx Conference
Published: 2022-11-15 (Crawled : 00:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: -1.71%
conference
BD to Present at the BofA Securities 2022 Healthcare Conference
Published: 2022-04-29 (Crawled : 22:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
conference
BD Board of Directors Approves embecta Spinoff and Declares Distribution of embecta Stock
Published: 2022-02-01 (Crawled : 00:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
distribution
BD Publishes 2021 Cybersecurity Annual Report
Published: 2022-01-06 (Crawled : 12:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
cybersecurity security
BD Announces New Distribution and Retail Partners for BD Veritor™ At-Home COVID-19 Test
Published: 2021-12-22 (Crawled : 13:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: 0.1%
H: 0.08%
C: -1.68%
covid-19 distribution covid test
BD Acquires Venclose, Inc. To Extend Treatment Innovations In Chronic Venous Disease
Published: 2021-12-02 (Crawled : 12:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: 1.52%
H: 1.75%
C: 0.07%
treatment disease
BD Issues 2021 Global Inclusion, Diversity and Equity Report
Published: 2021-12-01 (Crawled : 13:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
BD Receives Emergency Use Authorization for First At-Home COVID-19 Test to Use Smartphone to Interpret, Deliver Results
Published: 2021-08-25 (Crawled : 21:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -0.44%
H: 0.47%
C: 0.09%
covid test results liver merge authorized emergency use authorization
Becton, Dickinson and Company Announces Early Tender Results
Published: 2021-08-19 (Crawled : 11:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: 0.23%
H: 0.53%
C: -0.4%
results
BD Announces the Voluntary Recall of Specified Lots of ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator in the United States and U.S. Territories Due to Defective Applicator
Published: 2021-04-20 (Crawled : 19:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -0.09%
H: 0.73%
C: -0.88%
application
BD MAX™ Molecular Multi-Drug Resistant Tuberculosis Test To Be Included In WHO Updated Consolidated Guidelines On Tuberculosis
Published: 2021-04-13 (Crawled : 13:00) - biospace.com/
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -0.26%
H: 1.9%
C: 1.6%
test molecular drug
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
RWOD | $10.08 26.05% 5.6M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.